The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-18
DOI
10.1007/s11033-021-06547-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD47 Functionalization of Nanoparticles as a Poly(ethylene glycol) Alternative: A Novel Approach to Improve Drug Delivery
- (2021) Noushin Rezaei Vandchali et al. CURRENT DRUG TARGETS
- The role of nuclear factors as “Find-Me”/alarmin signals and immunostimulation in defective efferocytosis and related disorders
- (2020) Amir Tajbakhsh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
- (2020) Wenting Zhang et al. Frontiers in Immunology
- Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
- (2020) Jennifer Sun et al. Cancers
- Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin
- (2020) Seyed Mohammad Gheibi Hayat et al. Expert Opinion on Drug Delivery
- Phagocytosis of Apoptotic Cells in Resolution of Inflammation
- (2020) Ioannis Kourtzelis et al. Frontiers in Immunology
- miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
- (2020) Qing Xi et al. Frontiers in Immunology
- Differential modulation and prognostic values of immune-escape genes in uveal melanoma
- (2019) Maria Sofia Basile et al. PLoS One
- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
- (2019) Shu Lian et al. EBioMedicine
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
- (2019) Zi-ming Ye et al. Cell Death & Disease
- Effect of soluble cleavage products of important receptors/ligands on efferocytosis: Their role in inflammatory, autoimmune and cardiovascular disease
- (2019) Amir Tajbakhsh et al. AGEING RESEARCH REVIEWS
- HDAC6 Suppresses Let‐7i‐5p to Elicit TSP1/CD47‐mediated Anti‐tumorigenesis and Phagocytosis of Hepatocellular Carcinoma
- (2019) Hee Doo Yang et al. HEPATOLOGY
- miR‐378a Modulates Macrophage Phagocytosis and Differentiation through Targeting CD47‐SIRPα Axis in Atherosclerosis
- (2019) Wenna Chen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
- (2019) Weige Tan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
- (2019) Maria Cristina Petralia et al. MOLECULES
- MiR-34a inhibits spinal cord injury and blocks spinal cord neuron apoptosis by activating phatidylinositol 3-kinase (PI3K)/AKT pathway through targeting CD47
- (2019) Liao Qi et al. CURRENT NEUROVASCULAR RESEARCH
- Efferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs
- (2019) Amir Tajbakhsh et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma
- (2019) Nasrin Rastgoo et al. HAEMATOLOGICA
- MicroRNA delivery through nanoparticles
- (2019) Sharon Wei Ling Lee et al. JOURNAL OF CONTROLLED RELEASE
- Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer
- (2018) Tiphaine de Foucher et al. Journal of Translational Medicine
- MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
- (2018) Wei Huang et al. Molecular Cancer
- The prognostic and therapeutic values of long noncoding RNA PANDAR in colorectal cancer
- (2018) Mahdi Rivandi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- microRNA-222 Attenuates Mitochondrial Dysfunction During Transmissible Gastroenteritis Virus Infection
- (2018) Xiaomin Zhao et al. MOLECULAR & CELLULAR PROTEOMICS
- 4Mu decreases CD47 expression on hepatic cancer stem cells and primes a potent antitumor T-cell response induced by interleukin-12
- (2018) Marcelo M. Rodríguez et al. MOLECULAR THERAPY
- Efferocytosis in the tumor microenvironment
- (2018) Thomas A. Werfel et al. Seminars in Immunopathology
- Nanomaterials for modulating innate immune cells in cancer immunotherapy
- (2018) Quoc-Viet Le et al. Asian Journal of Pharmaceutical Sciences
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD47 receptor as a primary target for cancer therapy
- (2017) N. M. Ratnikova et al. MOLECULAR BIOLOGY
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- Aberrant Reduction of MiR-141 Increased CD47/CUL3 in Hirschsprung's Disease
- (2017) Weibing Tang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
- (2016) Liang Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- RNAi-Mediated Down-Regulation of CD47 Protects against Ischemia/Reperfusion-Induced Myocardial Damage via Activation of eNOS in a Rat Model
- (2016) Hui-bo Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer
- (2016) Charles J. Bowerman et al. NANO LETTERS
- Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells
- (2016) Qi Gao et al. Cell Death & Disease
- miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
- (2016) R. Rupaimoole et al. Cancer Discovery
- A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
- (2016) Sukhbir Kaur et al. Oncotarget
- Role of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis
- (2016) Chaoyun Pan et al. Scientific Reports
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA
- (2016) Francesca Montani et al. EBioMedicine
- MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
- (2015) M Pichler et al. BRITISH JOURNAL OF CANCER
- Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
- (2015) Chi Li et al. CURRENT GENOMICS
- CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation
- (2015) Thomas W. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
- (2015) Huimin Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
- (2015) Seung Yeob Yang et al. Oncotarget
- PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
- (2015) Guang-Tao Yu et al. Oncotarget
- MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation
- (2014) Ce Dou et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents
- (2014) Volker Baumann et al. Future Medicinal Chemistry
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- Biogenesis and the regulation of the maturation of miRNAs
- (2013) Nham Tran et al. Essays in Biochemistry
- MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α
- (2013) Dihan Zhu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
- (2013) Yuhua Wang et al. MOLECULAR THERAPY
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
- (2013) P. L. Rodriguez et al. SCIENCE
- Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1
- (2012) Philip M. Bauer et al. CARDIOVASCULAR RESEARCH
- Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47
- (2012) David R Soto-Pantoja et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA and cancer
- (2012) Martin D. Jansson et al. Molecular Oncology
- CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma
- (2012) SHIGEMASA SUZUKI et al. ONCOLOGY REPORTS
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy
- (2011) Kevin Scott Goudy et al. Frontiers in Microbiology
- MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
- (2010) Zhang Chun-zhi et al. BMC CANCER
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- RNAi and microRNA-oriented therapy in cancer: rationales, promises and challenges
- (2010) Thomas Duchaine et al. Current Oncology
- Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
- (2010) Shyh-Dar Li et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
- (2009) Andreas Junker et al. BRAIN
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Signal regulatory protein alpha (SIRPα)/CD47 interaction and function
- (2009) A Neil Barclay CURRENT OPINION IN IMMUNOLOGY
- Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
- (2009) J. B. Maxhimer et al. Science Translational Medicine
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
- (2008) Richard K. Tsai et al. JOURNAL OF CELL BIOLOGY
- An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor
- (2008) Sumio Chono et al. JOURNAL OF CONTROLLED RELEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started